  We present a practical guide for the analysis of regression discontinuity
(RD) designs in biomedical contexts. We begin by introducing key concepts,
assumptions, and estimands within both the continuity-based framework and the
local randomization framework. We then discuss modern estimation and inference
methods within both frameworks, including approaches for bandwidth or local
neighborhood selection, optimal treatment effect point estimation, and robust
bias-corrected inference methods for uncertainty quantification. We also
overview empirical falsification tests that can be used to support key
assumptions. Our discussion focuses on two particular features that are
relevant in biomedical research: (i) fuzzy RD designs, which often arise when
therapeutic treatments are based on clinical guidelines but patients with
scores near the cutoff are treated contrary to the assignment rule; and (ii) RD
designs with discrete scores, which are ubiquitous in biomedical applications.
We illustrate our discussion with three empirical applications: the effect of
CD4 guidelines for anti-retroviral therapy on retention of HIV patients in
South Africa, the effect of genetic guidelines for chemotherapy on breast
cancer recurrence in the United States, and the effects of age-based patient
cost-sharing on healthcare utilization in Taiwan. We provide replication
materials employing publicly available statistical software in Python, R and
Stata, offering researchers all necessary tools to conduct an RD analysis.
